T1	Participants 70 105	patients with stable schizophrenia:
T2	Participants 262 297	patients with stable schizophrenia.
T3	Participants 351 621	40 patients with schizophrenia (Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition) who were stabilized on risperidone for a minimum of 8 weeks were randomized to either memantine (20 mg) or placebo in addition to risperidone, 6 mg/d, for eight weeks.
T4	Participants 900 995	All 40 patients had at least one postbaseline measurement, and 38 patients completed the trial.
